Resmed (RSMDF) Cash from Investing Activities Growth (1y) (2010 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 0.00% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | -186.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -186.92% |
| Mar 31, 2026 | -82.56% |
| Dec 31, 2025 | -38.84% |
| Sep 30, 2025 | -2,550.05% |
| Jun 30, 2025 | -187.50% |
| Mar 31, 2025 | 4.12% |
| Dec 31, 2024 | 10.82% |
| Sep 30, 2024 | 101.44% |
| Jun 30, 2024 | 0.03% |
| Mar 31, 2024 | -17.96% |
| Dec 31, 2023 | 95.99% |
| Sep 30, 2023 | -153.34% |
| Jun 30, 2023 | 15.78% |
| Mar 31, 2023 | 43.22% |
| Dec 31, 2022 | -1,132.07% |
| Sep 30, 2022 | -40.44% |
| Jun 30, 2022 | -14.91% |
| Mar 31, 2022 | 15.56% |
| Dec 31, 2021 | -180.87% |
| Sep 30, 2021 | -89.39% |